Muscles Strength and Gait Parameteres After TKA
Launched by MEDICAL UNIVERSITY OF WARSAW · Sep 24, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how muscle strength and walking abilities change after patients undergo Total Knee Arthroplasty (TKA), a common surgery for severe knee arthritis. While many patients find relief from their knee pain after the surgery, about 20% are not satisfied with their results. The study aims to understand how factors like muscle strength and walking patterns affect recovery and overall knee function, using feedback from participants through simple questionnaires.
To join the trial, participants need to be over 50 years old and have a specific type of severe knee arthritis. They should also be willing to sign a consent form. However, people with certain conditions, like previous hip replacements or serious mental or muscle disorders, cannot participate. Those who take part can expect to share their experiences and outcomes after their knee surgery, helping researchers find ways to improve recovery for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • III° or IV° grade knee osteoarthritis
- • Age over 50
- • Patients with signed consent
- Exclusion Criteria:
- • Undergone total hip replacement
- • Previous femur fracture in anamnesis
- • Undergone corrective osteotomy
- • Active/ Chronic neoplastic disease
- • Significant deformation of lower limb axis
- • Mental disorders
- • Muscular disorders
About Medical University Of Warsaw
The Medical University of Warsaw is a leading academic institution dedicated to advancing healthcare through innovative research and education. Renowned for its commitment to excellence in medical training and clinical practice, the university actively engages in a diverse range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. With a robust infrastructure and a multidisciplinary team of experts, the Medical University of Warsaw fosters collaboration in the development of novel therapies and interventions, contributing significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, , Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported